MEF2A and renal cell carcinoma: Therefore, we conclude that MEF2A overexpression inhibits RCC progression by suppressing the Wnt/β‐catenin signalling pathway, arresting the G1/S transition of the cell cycle and promoting RCC cell apoptosis.